Loading...
EXENS logo

ExosensENXTPA:EXENS Stock Report

Market Cap €2.4b
Share Price
€45.60
n/a
1Y168.0%
7D-2.6%
Portfolio Value
View

Exosens

ENXTPA:EXENS Stock Report

Market Cap: €2.4b

Exosens (EXENS) Stock Overview

Engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. More details

EXENS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance3/6
Financial Health5/6
Dividends0/6

EXENS Community Fair Values

Create Narrative

See what 22 others think this stock is worth. Follow their fair value or set your own to get alerts.

€60.04
FV
24.1% undervalued intrinsic discount
12.74%
Revenue growth p.a.
1users have liked this narrative
1users have commented on this narrative
8users have followed this narrative

Exosens Competitors

Price History & Performance

Summary of share price highs, lows and changes for Exosens
Historical stock prices
Current Share Price€47.00
52 Week High€53.00
52 Week Low€16.84
Beta0
1 Month Change2.51%
3 Month Change7.06%
1 Year Change167.96%
3 Year Changen/a
5 Year Changen/a
Change since IPO108.89%

Recent News & Updates

Recent updates

Calculating The Intrinsic Value Of Exosens (EPA:EXENS)

Oct 27
Calculating The Intrinsic Value Of Exosens (EPA:EXENS)

Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly

Sep 15
Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly

Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

Aug 03
Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 26% Above Its Share Price

Jul 25
Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 26% Above Its Share Price

Exosens (EPA:EXENS) Might Have The Makings Of A Multi-Bagger

Jul 06
Exosens (EPA:EXENS) Might Have The Makings Of A Multi-Bagger

Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly

Jun 13
Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly
User avatar

Elevated Defense Spending Will Challenge Overvaluation And Unleash Upside

Growth and profitability expectations rely on sustained global defense spending, rapid demand capture, and seamless operational execution, making them vulnerable to defense cycle shifts and integrati

Market Participants Recognise Exosens' (EPA:EXENS) Revenues Pushing Shares 27% Higher

May 29
Market Participants Recognise Exosens' (EPA:EXENS) Revenues Pushing Shares 27% Higher

€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Mar 06
€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Optimistic Investors Push Exosens (EPA:EXENS) Shares Up 37% But Growth Is Lacking

Mar 05
Optimistic Investors Push Exosens (EPA:EXENS) Shares Up 37% But Growth Is Lacking

Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 96% Above Its Share Price

Feb 14
Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 96% Above Its Share Price

Shareholder Returns

EXENSFR Aerospace & DefenseFR Market
7D-2.6%-0.6%-0.2%
1Y168.0%33.3%8.0%

Return vs Industry: EXENS exceeded the French Aerospace & Defense industry which returned 33.3% over the past year.

Return vs Market: EXENS exceeded the French Market which returned 8% over the past year.

Price Volatility

Is EXENS's price volatile compared to industry and market?
EXENS volatility
EXENS Average Weekly Movement6.9%
Aerospace & Defense Industry Average Movement6.0%
Market Average Movement4.5%
10% most volatile stocks in FR Market10.4%
10% least volatile stocks in FR Market2.3%

Stable Share Price: EXENS's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: EXENS's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
19371,400Jerome Cerisierwww.exosens.com

Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultraviolet, short, medium, and long wave infrared, visible - near infrared, and mid-wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for scientific applications; and gamma and neutron detectors, and mineral insulated extensions. The company also provides power tubes and microwave devices; and methane airborne detection solutions.

Exosens Fundamentals Summary

How do Exosens's earnings and revenue compare to its market cap?
EXENS fundamental statistics
Market cap€2.39b
Earnings (TTM)€55.73m
Revenue (TTM)€431.70m
42.8x
P/E Ratio
5.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EXENS income statement (TTM)
Revenue€431.70m
Cost of Revenue€173.02m
Gross Profit€258.68m
Other Expenses€202.96m
Earnings€55.73m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Feb 23, 2026

Earnings per share (EPS)1.10
Gross Margin59.92%
Net Profit Margin12.91%
Debt/Equity Ratio58.1%

How did EXENS perform over the long term?

See historical performance and comparison

Dividends

0.2%
Current Dividend Yield
9%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/15 17:04
End of Day Share Price 2025/12/12 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Exosens is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Amelie Dueckelmann-DublanyBerenberg
Laurent GelebartBNP Paribas
Charles ArmitageCitigroup Inc